Home > English > International Treaties > Full Text
Hits Focused   English 中文
Copy Full Text Download Favorite Operation
  • Format:
  • View:

Joint Statement of the International Forum on COVID-19 Vaccine Cooperation

新冠疫苗合作国际论坛联合声明(全文)

[CLI Code] CLI.T.10252(EN)  Statement
  • Joint Statement of the International Forum on COVID-19 Vaccine Cooperation

  • 新冠疫苗合作国际论坛联合声明(全文)

  • (August 5, 2021)
  • (2021年8月5日)

  • Jointly launched by Argentina, Brazil, Chile, China, Colombia, the Dominican Republic, Ecuador, Egypt, Hungary, Indonesia, Kenya, Malaysia, Mexico, Morocco, Pakistan, the Philippines, Serbia, South Africa, Sri Lanka, Thailand, Turkey, the United Arab Emirates and Uzbekistan at the first meeting of the International Forum on COVID-19 Vaccine Cooperation on August 5, 2021.
  • 阿根廷、巴西、智利、中国、哥伦比亚、多米尼加、厄瓜多尔、埃及、匈牙利、印度尼西亚、肯尼亚、马来西亚、墨西哥、摩洛哥、巴基斯坦、菲律宾、塞尔维亚、南非、斯里兰卡、泰国、土耳其、阿联酋和乌兹别克斯坦,于2021年8月5日在新冠疫苗合作国际论坛首次会议期间,共同发表联合声明。
  • 1. We recognize that solidarity and cooperation are key to fighting against the COVID-19 pandemic, a challenge confronting all countries in the world. We must champion the vision of building a global community of health for all, put people and their lives first and make concerted and coordinated efforts to address the challenge.
  • 一、我们认为新冠肺炎疫情大流行是全球面临的共同挑战,应秉持人类卫生健康共同体理念,坚持人民至上、生命至上,团结协作应对疫情挑战。
  • 2. We recognize the importance of COVID-19 vaccination as a global public good, and call upon all parties to step up efforts to make vaccines more accessible and affordable in developing countries, including making utmost efforts to provide vaccines for developing countries, LDCs in particular.
  • 二、我们强调新冠疫苗作为全球公共产品的重要意义,呼吁各方为实现疫苗在发展中国家的可及性和可负担性继续努力,尽可能向发展中国家特别是最不发达国家提供疫苗。
  • Tel: +86 (10) 8268-9699 or +86 (10) 8266-8266 (ext. 153)
  • Mobile: +86 133-1157-0713
  • Fax: +86 (10) 8266-8268
  • E-mail: database@chinalawinfo.com
© Pkulaw (www.pkulaw.com) provides various professional solutions in such fields as legal information, law knowledge and legal software. Pkulaw provides you with abundant reference materials. When you invoke articles of laws and regulations, please check them with the standard texts.
You are welcome to view all our products and services. Pkulaw Express:How to quickly find information you need? What are the new features of Pkulaw V6?

Scan QR Code and Read on Mobile

智能检索

Welcome to V6

We will provide better legal search services for you

Back to V5 Still in V6

Expiration Reminder

Your partial permission to access Pkulaw.com expired on May 31, 2022.Upon expiry your account can still be used, but some access will be limited.

You can renew your subscription now by clicking the button below.Pkulaw.com welcomes you to participate in our Mid-Year Lucky Draw to win up to 10,000-yuan gift when you buy 3,600 yuan or more.

Ok Renew

Expiration Reminder

Your partial permission to access Pkulaw.com expires on May 31, 2022. Upon expiry your account can still be used, but some access will be limited.

You can renew your subscription now by clicking the button below. Pkulaw.com welcomes you to participate in our Mid-Year Lucky Draw to win up to 10,000-yuan gift when you buy 3,600 yuan or more.

Ok Renew